Convertible Debt - Related Party (Detail Textuals 1)
|
1 Months Ended |
9 Months Ended |
12 Months Ended |
|
Jan. 19, 2019
$ / shares
shares
|
Jan. 19, 2018
$ / shares
shares
|
Dec. 28, 2017
USD ($)
Day
$ / shares
|
Sep. 30, 2019
USD ($)
|
Sep. 30, 2018
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
| Short-term Debt [Line Items] |
|
|
|
|
|
|
|
| Aggregate gross proceeds |
|
|
|
|
|
$ 900,000
|
|
| Proceeds from secured convertible promissory note - related party |
|
|
|
|
$ 400,000
|
400,000
|
$ 500,000
|
| Funding of remaining bridge loan |
|
|
|
$ 9,301
|
|
|
154,092
|
| Convertible debt |
|
|
|
|
|
|
$ 235,000
|
| Loss on extinguishment of secured convertible promissory note - related party |
|
|
|
|
$ (590,392)
|
$ (590,392)
|
|
| Emerald Health Sciences Inc |
|
|
|
|
|
|
|
| Short-term Debt [Line Items] |
|
|
|
|
|
|
|
| Initial conversion price | $ / shares |
|
$ 0.10
|
|
|
|
|
|
| Number of notes converted into common stock | shares |
|
9,000,000
|
|
|
|
|
|
| Effective interest rate |
|
|
|
|
13.94%
|
13.94%
|
13.94%
|
| Emerald Health Sciences Inc | Subsequent Event |
|
|
|
|
|
|
|
| Short-term Debt [Line Items] |
|
|
|
|
|
|
|
| Initial conversion price | $ / shares |
$ 0.10
|
|
|
|
|
|
|
| Number of notes converted into common stock | shares |
9,000,000
|
|
|
|
|
|
|
| Bridge Loan | Secured promissory note and security agreement | Emerald Health Sciences Inc |
|
|
|
|
|
|
|
| Short-term Debt [Line Items] |
|
|
|
|
|
|
|
| Aggregate gross proceeds |
|
|
$ 900,000
|
|
|
|
|
| Bridge loan interest rate |
|
|
12.00%
|
|
|
|
|
| Initial conversion price | $ / shares |
|
$ 0.10
|
$ 0.10
|
|
|
|
|
| Proceeds from secured convertible promissory note - related party |
|
|
$ 500,000
|
|
|
|
|
| Funding of remaining bridge loan |
|
|
400,000
|
|
|
|
|
| Convertible debt |
|
|
265,000
|
|
|
|
|
| Additional conversion liability |
|
|
$ 360,000
|
|
|
|
|
| Number of trading days as of financing close date | Day |
|
|
1
|
|
|
|
|